Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 26, 2021 | Sr. VP/GM, Global VIT | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 419 | $26.10 | 46,244 | |
| Jul 26, 2021 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,105 | $26.10 | 359,167 | |
| Jul 26, 2021 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 353 | $26.10 | 68,308 | |
| Jul 21, 2021 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,738 | -- | 42,401 | |
| Jul 21, 2021 | SVP/GM, Vascular Access | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,923 | -- | 11,923 | |
| Jul 21, 2021 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,388 | -- | 26,979 | |
| Jul 21, 2021 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,777 | -- | 8,777 | |
| Jul 21, 2021 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,923 | -- | 11,923 | |
| Jul 21, 2021 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,842 | -- | 46,663 | |
| Jul 21, 2021 | SVP/GM, VIT | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,684 | -- | 5,684 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.